Suscribirse

Does total wrist denervation give reliable long-term results? Survival curve with an average follow-up of 8.2 years - 24/08/21

Doi : 10.1016/j.otsr.2021.102967 
Arthur Dellestable a, Damien Cheval b, Nathalie Kerfant c, d, e, Eric Stindel a, c, d, Dominique Le Nen a, d, Hoel Letissier a, c, d,
a Service de Chirurgie Orthopédique et Traumatologique, Hôpital de la Cavale Blanche, boulevard Tanguy Prigent, 29200 Brest, France 
b Service de chirurgie orthopédique et traumatologique, avenue Yves Thépot, Centre Hospitalier De Cornouaille, 29107 Quimper, France 
c LaTIM, INSERM, UMR 1101, SFR IBSAM, Avenue Foch, 29200 Brest, France 
d Université de Bretagne Occidentale, UBO, Brest, 29200 France 
e Service de Chirurgie Plastique et Reconstructrice, Hôpital de la Cavale Blanche, boulevard Tanguy Prigent, 29200 Brest, France 

Corresponding author at: Service de Chirurgie Orthopédique et Traumatologique, Hôpital de la Cavale Blanche, boulevard Tanguy Prigent, 29200 Brest, France.Service de Chirurgie Orthopédique et Traumatologique, Hôpital de la Cavale Blancheboulevard Tanguy PrigentBrest29200France

Bienvenido a EM-consulte, la referencia de los profesionales de la salud.
Artículo gratuito.

Conéctese para beneficiarse!

Abstract

Introduction

Pain is the main reason why patients consult for degenerative and posttraumatic wrist conditions. While the many surgical techniques make choosing the appropriate procedure difficult, total wrist denervation, which has an “analgesic” aim, remains an accessible therapeutic solution to treat this symptomatology. Nevertheless, long-term results remain controversial, and few studies have focused on the survival of this procedure.

Hypothesis

Total wrist denervation provides lasting pain relief.

Patients and methods

This was a single center, single operator (DLN), retrospective observational study. We analyzed 63 wrists. The mean age at the time of the procedure was 53.7 years. We verified the primary endpoint for survival, which included no further analgesic procedures and no significant residual pain (NRS3). Patient satisfaction and the quality of the wrist function were also assessed.

Results

The mean follow-up was 8.2 years. Some of the patients (12.7%) did not respond to treatment. We reported 1 neuroma of the superficial sensory branch of the radial nerve, 2 CRPS and 11 revision surgeries. We observed that the treatment became less effective over time. The median survival was 8.8 years. The survival rate of the procedure fell to 13.5% at the last follow-up. The mean residual pain was 3.4 on a numerical rating scale and the mean DASH score was 23.5. The mean satisfaction level, on a scale from 0 to 10, was 7.3 and most patients (79.6%) would undergo this procedure again.

Discussion

Survival of the total wrist denervation at the last follow-up was low in our study. Even though the treatment became less effective over time, the quality of the wrist function remained satisfactory and similar to the different studies previously published on the subject. There were very few complications and revisions.

Conclusion

Total wrist denervation therefore remains an interesting surgical solution for patients with chronic wrist pain as it preserves mobility.

Level of Evidence

IV; Single center, single operator retrospective observational study.

El texto completo de este artículo está disponible en PDF.

Keywords : Wrist denervation, Wrist osteoarthritis, Chronic pain, Survival study, Long-term results


Esquema


© 2021  Elsevier Masson SAS. Reservados todos los derechos.
Añadir a mi biblioteca Eliminar de mi biblioteca Imprimir
Exportación

    Exportación citas

  • Fichero

  • Contenido

Vol 107 - N° 5

Artículo 102967- septembre 2021 Regresar al número
Artículo precedente Artículo precedente
  • Comparison of subjective outcomes of Darrach and Sauvé–Kapandji procedures at a minimum 2 years’ follow-up
  • Steven Roulet, Ann Williot, Clara Sos, Matthieu Mazaleyrat, Emilie Marteau, Jacky Laulan, Guillaume Bacle
| Artículo siguiente Artículo siguiente
  • Double trapeziometacarpal and scaphotrapeziotrapezoidal pyrocarbon interposition implants for pantrapezial arthritis: Midterm results and surgical technique
  • Camilo Chaves, Philippe Bellemère

Bienvenido a EM-consulte, la referencia de los profesionales de la salud.

@@150455@@ Voir plus

Mi cuenta


Declaración CNIL

EM-CONSULTE.COM se declara a la CNIL, la declaración N º 1286925.

En virtud de la Ley N º 78-17 del 6 de enero de 1978, relativa a las computadoras, archivos y libertades, usted tiene el derecho de oposición (art.26 de la ley), el acceso (art.34 a 38 Ley), y correcta (artículo 36 de la ley) los datos que le conciernen. Por lo tanto, usted puede pedir que se corrija, complementado, clarificado, actualizado o suprimido información sobre usted que son inexactos, incompletos, engañosos, obsoletos o cuya recogida o de conservación o uso está prohibido.
La información personal sobre los visitantes de nuestro sitio, incluyendo su identidad, son confidenciales.
El jefe del sitio en el honor se compromete a respetar la confidencialidad de los requisitos legales aplicables en Francia y no de revelar dicha información a terceros.


Todo el contenido en este sitio: Copyright © 2026 Elsevier, sus licenciantes y colaboradores. Se reservan todos los derechos, incluidos los de minería de texto y datos, entrenamiento de IA y tecnologías similares. Para todo el contenido de acceso abierto, se aplican los términos de licencia de Creative Commons.